MX2022009303A - Composicion farmaceutica adecuada para la administracion vaginal. - Google Patents

Composicion farmaceutica adecuada para la administracion vaginal.

Info

Publication number
MX2022009303A
MX2022009303A MX2022009303A MX2022009303A MX2022009303A MX 2022009303 A MX2022009303 A MX 2022009303A MX 2022009303 A MX2022009303 A MX 2022009303A MX 2022009303 A MX2022009303 A MX 2022009303A MX 2022009303 A MX2022009303 A MX 2022009303A
Authority
MX
Mexico
Prior art keywords
vaginal delivery
pharmaceutical composition
composition suitable
combination
fenticonazole
Prior art date
Application number
MX2022009303A
Other languages
English (en)
Inventor
Demirel Gulay Yelken
Original Assignee
Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi filed Critical Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi
Publication of MX2022009303A publication Critical patent/MX2022009303A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de una combinación que comprende fenticonazol y un agente antibacteriano en un procedimiento terapéutico en mujeres que tienen afecciones del sistema vulvovaginal donde está indicada dicha combinación de agentes activos. Las composiciones farmacéuticas adecuadas para la administración vaginal de una combinación de fenticonazol con un agente antibacteriano, opcionalmente uno o más analgésicos o anestésicos locales, y excipientes o portadores farmacéuticamente aceptables.
MX2022009303A 2020-01-31 2021-01-29 Composicion farmaceutica adecuada para la administracion vaginal. MX2022009303A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202001511 2020-01-31
PCT/TR2021/050086 WO2021154188A1 (en) 2020-01-31 2021-01-29 Pharmaceutical composition suitable for vaginal delivery

Publications (1)

Publication Number Publication Date
MX2022009303A true MX2022009303A (es) 2022-09-19

Family

ID=77079220

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009303A MX2022009303A (es) 2020-01-31 2021-01-29 Composicion farmaceutica adecuada para la administracion vaginal.

Country Status (5)

Country Link
EP (1) EP4096655A4 (es)
BR (1) BR112022015112A2 (es)
EC (1) ECSP22067445A (es)
MX (1) MX2022009303A (es)
WO (1) WO2021154188A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
US20060137684A1 (en) * 2004-12-01 2006-06-29 Celeste Evans Compositions and methods of treating irritation and kit therefor
CN103690476A (zh) * 2014-01-06 2014-04-02 海南海力制药有限公司 微粉化硝酸芬替康唑制剂组合物及其制备方法
TR201413590A3 (en) * 2014-11-17 2021-06-21 Pharmaceutical composition for use in treatment of vaginal infection comprises active substance or its derivative exhibiting antiprotozoal activity, and local anesthetic agent
US20170165233A1 (en) * 2014-12-20 2017-06-15 John Malcolm Hall Gregg Antimicrobial drug synthesis and therapeutic compositions
RU2674765C2 (ru) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Антигрибковая композиция эвтектического типа (варианты)
CN108079098A (zh) * 2018-02-28 2018-05-29 翔宇药业股份有限公司 抗真菌感染的药物制剂及其制作方法
CN108210448A (zh) * 2018-04-09 2018-06-29 翔宇药业股份有限公司 硝酸芬替康唑栓剂及其应用

Also Published As

Publication number Publication date
EP4096655A4 (en) 2024-02-28
BR112022015112A2 (pt) 2022-09-27
ECSP22067445A (es) 2022-11-30
EP4096655A1 (en) 2022-12-07
WO2021154188A1 (en) 2021-08-05

Similar Documents

Publication Publication Date Title
ATE347879T1 (de) Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
NZ603579A (en) Controlled release formulations
NZ552047A (en) Method of treatment of endobronchial infections
US9314482B2 (en) Methods and compositions for promoting wound healing
NZ597339A (en) Continuous administration of cilengitide in cancer treatments
US20040151765A1 (en) Methods and compositions for wound management
BR0213585A (pt) Composição vaginal farmacêutica, e, usos de um agente de tratamento antidisrìtmico e de um carreador bioadesivo de liberação prolongada farmaceuticamente aceitável, e de um agente de tratamento anestésico local e de um carregador bioadesivo de liberação prolongada farmaceuticamente aceitável
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
AR119031A1 (es) Formulaciones farmacéuticas antibacterianas de amplio espectro que comprenden lisozima y métodos de utilización de la misma
MX2022009303A (es) Composicion farmaceutica adecuada para la administracion vaginal.
US7323184B2 (en) Compositions and methods for the treatment of wounds and the reduction of scar formation
EP3210619A2 (en) Topical formulation for treating skin or mucosal infections, preparation method and uses thereof
Romanowski et al. Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis
Valadares et al. Genitourinary syndrome of menopause
Jannati et al. Comparison of therapeutic response of keloids to cryotherapy plus intralesional triamcinolone acetonide or verapamil hydrochloride
MX2023002424A (es) Perforacion de mucosa.
MX2022015742A (es) Formas farmaceuticas osmoticas que comprenden deutetrabenazina y metodos de uso de las mismas.
MX2022015760A (es) Inhibidor del receptor tipo toll 7 (tlr7) en combinacion con prednisolona o hidroxicloroquina para el tratamiento del lupus eritematoso cutaneo.
WO2009016379A3 (en) Nr4a agonists ( 6-mercaptopurine) for inhibition of non-ocular scarring
SALMON et al. THERAPEUTIC EFFECTIVENESS OF ORALLY ADMINISTERED ETHINYL ESTRADIOL
CA2431519A1 (en) Topical composition and method for treating urinary stress incontinence
CO6241114A2 (es) Composicion farmaceutica que comprende la combinacion del agente antimicrobiano ciprofloxacino y el agente antioxidante acido ascorbico para el tratamiento de infecciones urinarias
Tehranian et al. The effect of adding hyoscine to vaginal misoprostol on abortion induction success rate.
MX2023003097A (es) Composiciones farmaceuticas que comprenden un oligonucleotido antisentido para administracion oral.